103 related articles for article (PubMed ID: 7769806)
1. Relations between myocardial contractility, myosin phenotype, and plasma angiotensin-converting enzyme activity in the cardiomyopathic hamster.
Lambert F; Lecarpentier Y; Lompré AM; Scalbert E; Desché P; Chemla D
J Cardiovasc Pharmacol; 1995 Mar; 25(3):410-5. PubMed ID: 7769806
[TBL] [Abstract][Full Text] [Related]
2. Effects of perindopril on myocardial inotropy, lusitropy and economy, and on diaphragmatic contractility in the cardiomyopathic Syrian hamster.
Chemla D; Scalbert E; Desche P; Pourny JC; Lambert F; Lecarpentier Y
J Pharmacol Exp Ther; 1992 Aug; 262(2):516-25. PubMed ID: 1501112
[TBL] [Abstract][Full Text] [Related]
3. Effects of angiotensin converting enzyme inhibition on crossbridge properties of diaphragm in cardiomyopathic hamsters of the dilated bio 53-58 strain.
Lecarpentier Y; Coirault C; Lerebours G; Desche P; Scalbert E; Lambert F; Chemla D
Am J Respir Crit Care Med; 1997 Feb; 155(2):630-6. PubMed ID: 9032205
[TBL] [Abstract][Full Text] [Related]
4. Effects of early and late therapy with perindopril on survival and myocardial inotropic state in experimental dilated cardiomyopathy.
Chemla D; Scalbert E; Desché P; Lerebours G; Suard I; Lecarpentier Y
J Cardiovasc Pharmacol; 1994 Jul; 24(1):151-7. PubMed ID: 7521480
[TBL] [Abstract][Full Text] [Related]
5. Myocardial effects of early therapy with perindopril during experimental cardiomyopathy.
Chemla D; Scalbert E; Desché P; Pourny JC; Lambert F; Lecarpentier Y
Am J Cardiol; 1993 Jun; 71(17):41E-47E. PubMed ID: 8328367
[TBL] [Abstract][Full Text] [Related]
6. Verapamil preserves myocardial contractility in the hereditary cardiomyopathy of the Syrian hamster.
Rouleau JL; Chuck LH; Hollosi G; Kidd P; Sievers RE; Wikman-Coffelt J; Parmley WW
Circ Res; 1982 Mar; 50(3):405-12. PubMed ID: 6460569
[TBL] [Abstract][Full Text] [Related]
7. [Protective effects of perindopril in an experimental model of cardiomyopathy].
Chemla D; Scalbert E; Desché P; Pourny JC; Lambert F; Lecarpentier Y
Arch Mal Coeur Vaiss; 1993 Feb; 86 Spec No 2():45-51. PubMed ID: 8215790
[TBL] [Abstract][Full Text] [Related]
8. Contractile properties of papillary muscle from young cardiomyopathic hamsters: effects of isoprenaline.
Rossner KL; Coudrai PR
Cardiovasc Res; 1986 Aug; 20(8):609-13. PubMed ID: 3791350
[TBL] [Abstract][Full Text] [Related]
9. Sarcoplasmic reticulum Ca2+ pumps in heart and diaphragm of cardiomyopathic hamster: effects of perindopril.
Anger M; Lambert F; Chemla D; Desche P; Scalbert E; Lompre AM; Lecarpentier Y
Am J Physiol; 1995 May; 268(5 Pt 2):H1947-53. PubMed ID: 7771544
[TBL] [Abstract][Full Text] [Related]
10. Age related changes in contractility and alpha 1 adrenergic responsiveness of myocardium from normal hamsters and hamsters with hereditary cardiomyopathy.
Li K; Rouleau JL
Cardiovasc Res; 1993 Jun; 27(6):968-73. PubMed ID: 8221787
[TBL] [Abstract][Full Text] [Related]
11. Effect of trimetazidine and verapamil on the cardiomyopathic hamster myosin phenotype.
D'hahan N; Taouil K; Janmot C; Morel JE
Br J Pharmacol; 1998 Feb; 123(4):611-6. PubMed ID: 9517378
[TBL] [Abstract][Full Text] [Related]
12. Altered distribution of myosin isoenzymes in the cardiomyopathic Syrian hamster (BIO 8.262).
Wiegand V; Stroh E; Henniges A; Lossnitzer K; Kreuzer H
Basic Res Cardiol; 1983; 78(6):665-70. PubMed ID: 6229245
[TBL] [Abstract][Full Text] [Related]
13. Radioligand binding and inotropic effects of ryanodine in the cardiomyopathic Syrian hamster.
Finkel MS; Shen L; Romeo RC; Oddis CV; Salama G
J Cardiovasc Pharmacol; 1992 Apr; 19(4):610-7. PubMed ID: 1380605
[TBL] [Abstract][Full Text] [Related]
14. Effects of quinapril, a new angiotensin converting enzyme inhibitor, on left ventricular failure and survival in the cardiomyopathic hamster. Hemodynamic, morphological, and biochemical correlates.
Haleen SJ; Weishaar RE; Overhiser RW; Bousley RF; Keiser JA; Rapundalo SR; Taylor DG
Circ Res; 1991 May; 68(5):1302-12. PubMed ID: 1850330
[TBL] [Abstract][Full Text] [Related]
15. Histochemistry of ventricular heavy-chain myosins in cardiomyopathic Syrian hamsters treated with D-600.
Jasmin G; Proschek L; Dechesne C; Léger J
Proc Soc Exp Biol Med; 1988 Jun; 188(2):142-8. PubMed ID: 3287384
[TBL] [Abstract][Full Text] [Related]
16. Tension-frequency relationships in normal and cardiomyopathic dog and hamster myocardium.
Li K; Rouleau JL
J Mol Cell Cardiol; 1995 Jun; 27(6):1251-61. PubMed ID: 8531207
[TBL] [Abstract][Full Text] [Related]
17. Effects of etomidate on the cardiac papillary muscle of normal hamsters and those with cardiomyopathy.
Riou B; Lecarpentier Y; Viars P
Anesthesiology; 1993 Jan; 78(1):83-90. PubMed ID: 8424576
[TBL] [Abstract][Full Text] [Related]
18. [Electromechanical responsiveness to alpha 1-adrenoceptor and angiotensin II receptor stimulation in the ventricular myocardium of hypertrophied and dilated cardiomyopathic Syrian hamsters].
Yamashita T
Hokkaido Igaku Zasshi; 1992 Nov; 67(6):815-29. PubMed ID: 1336480
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of shortening velocity, power, and acto-myosin crossbridge (CB) kinetics following long-term treatment with propionyl-L-carnitine, coenzyme Q10, and omega-3 fatty acids in BIO TO-2 cardiomyopathic Syrian hamsters papillary muscle.
Vargiu R; Littarru GP; Fraschini M; Perinu A; Tiano L; Capra A; Mancinelli R
Biofactors; 2010; 36(3):229-39. PubMed ID: 20533397
[TBL] [Abstract][Full Text] [Related]
20. Angiotensins and the failing heart. Enhanced positive inotropic response to angiotensin I in cardiomyopathic hamster heart in the presence of captopril.
Hirakata H; Fouad-Tarazi FM; Bumpus FM; Khosla M; Healy B; Husain A; Urata H; Kumagai H
Circ Res; 1990 Apr; 66(4):891-9. PubMed ID: 2180588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
